[PHARMA] YoY Annualized Quarter Result on 30-Jun-2013 [#2]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
16-Aug-2013
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2013
Quarter
30-Jun-2013 [#2]
Profit Trend
QoQ- -38.16%
YoY- -31.0%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
Revenue 2,181,982 1,969,498 1,987,488 1,875,944 1,806,964 1,563,526 1,335,790 8.51%
PBT 96,050 127,336 125,562 93,058 141,146 82,344 65,516 6.57%
Tax -27,828 -30,200 -40,356 -30,410 -50,870 -23,056 -17,862 7.66%
NP 68,222 97,136 85,206 62,648 90,276 59,288 47,654 6.15%
-
NP to SH 66,748 96,022 84,384 61,272 88,796 58,808 48,108 5.60%
-
Tax Rate 28.97% 23.72% 32.14% 32.68% 36.04% 28.00% 27.26% -
Total Cost 2,113,760 1,872,362 1,902,282 1,813,296 1,716,688 1,504,238 1,288,136 8.59%
-
Net Worth 524,041 527,991 502,162 481,681 481,282 451,381 417,306 3.86%
Dividend
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
Div 46,604 72,469 41,415 35,323 35,301 - 100,581 -12.02%
Div Payout % 69.82% 75.47% 49.08% 57.65% 39.76% - 209.07% -
Equity
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
Net Worth 524,041 527,991 502,162 481,681 481,282 451,381 417,306 3.86%
NOSH 258,913 258,819 258,846 258,968 117,672 106,962 107,001 15.85%
Ratio Analysis
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
NP Margin 3.13% 4.93% 4.29% 3.34% 5.00% 3.79% 3.57% -
ROE 12.74% 18.19% 16.80% 12.72% 18.45% 13.03% 11.53% -
Per Share
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
RPS 842.74 760.95 767.82 724.39 1,535.58 1,461.75 1,248.38 -6.33%
EPS 25.78 37.10 32.60 23.66 75.46 54.98 44.96 -8.84%
DPS 18.00 28.00 16.00 13.64 30.00 0.00 94.00 -24.06%
NAPS 2.024 2.04 1.94 1.86 4.09 4.22 3.90 -10.34%
Adjusted Per Share Value based on latest NOSH - 258,370
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
RPS 151.40 136.65 137.90 130.16 125.38 108.49 92.68 8.51%
EPS 4.63 6.66 5.86 4.25 6.16 4.08 3.34 5.58%
DPS 3.23 5.03 2.87 2.45 2.45 0.00 6.98 -12.04%
NAPS 0.3636 0.3663 0.3484 0.3342 0.3339 0.3132 0.2895 3.86%
Price Multiplier on Financial Quarter End Date
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
Date 30/06/16 30/06/15 30/06/14 28/06/13 29/06/12 30/06/11 30/06/10 -
Price 5.50 7.13 4.61 4.49 10.18 5.90 4.98 -
P/RPS 0.65 0.94 0.60 0.62 0.66 0.40 0.40 8.42%
P/EPS 21.33 19.22 14.14 18.98 13.49 10.73 11.08 11.52%
EY 4.69 5.20 7.07 5.27 7.41 9.32 9.03 -10.33%
DY 3.27 3.93 3.47 3.04 2.95 0.00 18.88 -25.31%
P/NAPS 2.72 3.50 2.38 2.41 2.49 1.40 1.28 13.37%
Price Multiplier on Announcement Date
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
Date 19/08/16 17/08/15 21/08/14 16/08/13 08/08/12 10/08/11 11/08/10 -
Price 5.62 5.65 4.62 4.66 8.83 5.90 4.95 -
P/RPS 0.67 0.74 0.60 0.64 0.58 0.40 0.40 8.96%
P/EPS 21.80 15.23 14.17 19.70 11.70 10.73 11.01 12.04%
EY 4.59 6.57 7.06 5.08 8.55 9.32 9.08 -10.73%
DY 3.20 4.96 3.46 2.93 3.40 0.00 18.99 -25.66%
P/NAPS 2.78 2.77 2.38 2.51 2.16 1.40 1.27 13.93%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment